Cargando…

Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study

OBJECTIVES: Glioblastoma (GBM) is the most common malignant primary brain tumor with local recurrence after radiotherapy (RT), the most common mode of failure. Standard RT practice applies the prescription dose uniformly across tumor volume disregarding radiological tumor heterogeneity. We present a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Yaru, Kosmin, Michael, Li, Zhuangling, Deng, Xiaonian, Li, Zihuang, Li, Xianming, Zhang, Ying, Royle, Gary, Manolopoulos, Spyros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2023
Materias:	Full Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230387/ https://www.ncbi.nlm.nih.gov/pubmed/37102792 http://dx.doi.org/10.1259/bjr.20220384

Ejemplares similares

RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2
por: Jiang, Liji, et al.
Publicado: (2017)

Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy
por: Bainbridge, Hannah E., et al.
Publicado: (2017)

Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study
por: Zindler, Jaap D., et al.
Publicado: (2018)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review
por: Khan, Muhammad, et al.
Publicado: (2021)

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
por: Haslett, Kate, et al.
Publicado: (2016)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
por: Landau, David B., et al.
Publicado: (2016)

Correction: Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
Publicado: (2016)

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
por: Liu, Ming, et al.
Publicado: (2017)

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
por: Nguyen, Dan, et al.
Publicado: (2014)

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
por: Fenwick, John D., et al.
Publicado: (2020)

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer
por: Dingemans, Anne-Marie C., et al.
Publicado: (2014)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
por: Giordano, Frank A, et al.
Publicado: (2014)

Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
por: Liu, Yue-E, et al.
Publicado: (2020)

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
por: Haslett, Kate, et al.
Publicado: (2021)

Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer
por: Hawranko, Robert, et al.
Publicado: (2022)

National trends in radiation dose escalation for glioblastoma
por: Wegner, Rodney E., et al.
Publicado: (2019)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
por: Spohn, Simon K. B., et al.
Publicado: (2021)

Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
por: Li, Zihuang, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2019)

Role of exosomal miRNAs in brain metastasis affected by radiotherapy
por: Li, Zihuang, et al.
Publicado: (2021)

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
por: Kusumawidjaja, Grace, et al.
Publicado: (2016)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

A serious adverse drug reaction probably induced by clonazepam: a case report of myotoxicity
por: Han, Xiaonian, et al.
Publicado: (2019)

An evaluation of an energy independent CT reconstruction algorithm for use in radiotherapy treatment planning
por: Tulip, Rachael, et al.
Publicado: (2023)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
por: Jo, Sunmi, et al.
Publicado: (2016)

Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
por: Pang, Yaru, et al.
Publicado: (2022)

Survival of glioblastoma treated with a moderately escalated radiation dose—Results of a retrospective analysis
por: Shieh, Li-Tsun, et al.
Publicado: (2020)

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
por: Gardner, Sharon L, et al.
Publicado: (2022)

Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy
por: Cicka, Danielle, et al.
Publicado: (2019)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2016)

Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy
por: Tini, Paolo, et al.
Publicado: (2017)

Hatemongers ride on echo chambers to escalate hate speech diffusion
por: Goel, Vasu, et al.
Publicado: (2023)

Advances in Radiotherapy for Glioblastoma
por: Mann, Justin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p6ukn34m92tupultc8vigejf0k